Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Jun 20;92(13):6152–6156. doi: 10.1073/pnas.92.13.6152

Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa.

M Cappello 1, G P Vlasuk 1, P W Bergum 1, S Huang 1, P J Hotez 1
PMCID: PMC41660  PMID: 7597095

Abstract

Human hookworm infection is a major cause of gastrointestinal blood loss and iron deficiency anemia, affecting up to one billion people in the developing world. These soil-transmitted helminths cause blood loss during attachment to the intestinal mucosa by lacerating capillaries and ingesting extravasated blood. We have isolated the major anticoagulant used by adult worms to facilitate feeding and exacerbate intestinal blood loss. This 8.7-kDa peptide, named the Ancylostoma caninum anticoagulant peptide (AcAP), was purified by using a combination of ion-exchange chromatography, gel-filtration chromatography, and reverse-phase HPLC. N-terminal sequencing of AcAP reveals no homology to any previously identified anticoagulant or protease inhibitor. Single-stage chromogenic assays reveal that AcAP is a highly potent and specific inhibitor of human coagulation, with an intrinsic K*i for the inhibition of free factor Xa of 323.5 pM. In plasma-based clotting time assays, AcAP was more effective at prolonging the prothrombin time than both recombinant hirudin and tick anticoagulant peptide. These data suggest that AcAP, a specific inhibitor of factor Xa, is one of the most potent naturally occurring anticoagulants described to date.

Full text

PDF
6152

Images in this article

6154Fig. 2
on p.6154

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bock P. E., Craig P. A., Olson S. T., Singh P. Isolation of human blood coagulation alpha-factor Xa by soybean trypsin inhibitor-sepharose chromatography and its active-site titration with fluorescein mono-p-guanidinobenzoate. Arch Biochem Biophys. 1989 Sep;273(2):375–388. doi: 10.1016/0003-9861(89)90496-7. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Cappello M., Clyne L. P., McPhedran P., Hotez P. J. Ancylostoma factor Xa inhibitor: partial purification and its identification as a major hookworm-derived anticoagulant in vitro. J Infect Dis. 1993 Jun;167(6):1474–1477. doi: 10.1093/infdis/167.6.1474. [DOI] [PubMed] [Google Scholar]
  4. Carroll S. M., Howse D. J., Grove D. I. The anticoagulant effects of the hookworm, ancylostoma ceylanicum: observations on human and dog blood in vitro and infected dogs in vivo. Thromb Haemost. 1984 Apr 30;51(2):222–227. [PubMed] [Google Scholar]
  5. Carson S. D. Computerized analysis of enzyme cascade reactions using continuous rate data obtained with an ELISA reader. Comput Programs Biomed. 1985;19(2-3):151–157. doi: 10.1016/0010-468x(85)90006-6. [DOI] [PubMed] [Google Scholar]
  6. Dunwiddie C. T., Smith D. E., Nutt E. M., Vlasuk G. P. Anticoagulant effects of the selective factor XA inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition. Thromb Res. 1991 Dec 15;64(6):787–794. doi: 10.1016/0049-3848(91)90081-7. [DOI] [PubMed] [Google Scholar]
  7. Lehman E. D., Joyce J. G., Bailey F. J., Markus H. Z., Schultz L. D., Dunwiddie C. T., Jacobson M. A., Miller W. J. Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae. Protein Expr Purif. 1993 Jun;4(3):247–255. doi: 10.1006/prep.1993.1032. [DOI] [PubMed] [Google Scholar]
  8. Morrison J. F., Walsh C. T. The behavior and significance of slow-binding enzyme inhibitors. Adv Enzymol Relat Areas Mol Biol. 1988;61:201–301. doi: 10.1002/9780470123072.ch5. [DOI] [PubMed] [Google Scholar]
  9. Moyle M., Foster D. L., McGrath D. E., Brown S. M., Laroche Y., De Meutter J., Stanssens P., Bogowitz C. A., Fried V. A., Ely J. A. A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18. J Biol Chem. 1994 Apr 1;269(13):10008–10015. [PubMed] [Google Scholar]
  10. Neeper M. P., Waxman L., Smith D. E., Schulman C. A., Sardana M., Ellis R. W., Schaffer L. W., Siegl P. K., Vlasuk G. P. Characterization of recombinant tick anticoagulant peptide. A highly selective inhibitor of blood coagulation factor Xa. J Biol Chem. 1990 Oct 15;265(29):17746–17752. [PubMed] [Google Scholar]
  11. Nutt E., Gasic T., Rodkey J., Gasic G. J., Jacobs J. W., Friedman P. A., Simpson E. The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure. J Biol Chem. 1988 Jul 25;263(21):10162–10167. [PubMed] [Google Scholar]
  12. Roche M., Layrisse M. The nature and causes of "hookworm anemia". Am J Trop Med Hyg. 1966 Nov;15(6):1029–1102. [PubMed] [Google Scholar]
  13. Ruf W., Miles D. J., Rehemtulla A., Edgington T. S. Mutational analysis of receptor and cofactor function of tissue factor. Methods Enzymol. 1993;222:209–224. doi: 10.1016/0076-6879(93)22015-8. [DOI] [PubMed] [Google Scholar]
  14. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987 Nov 1;166(2):368–379. doi: 10.1016/0003-2697(87)90587-2. [DOI] [PubMed] [Google Scholar]
  15. Spellman G. G., Jr, Nossel H. L. Anticoagulant activity of dog hookworm. Am J Physiol. 1971 Apr;220(4):922–927. doi: 10.1152/ajplegacy.1971.220.4.922. [DOI] [PubMed] [Google Scholar]
  16. Tuszynski G. P., Gasic T. B., Gasic G. J. Isolation and characterization of antistasin. An inhibitor of metastasis and coagulation. J Biol Chem. 1987 Jul 15;262(20):9718–9723. [PubMed] [Google Scholar]
  17. Waxman L., Smith D. E., Arcuri K. E., Vlasuk G. P. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science. 1990 May 4;248(4955):593–596. doi: 10.1126/science.2333510. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES